vs

Side-by-side financial comparison of Huntsman CORP (HUN) and Invesco (IVZ). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $1.4B, roughly 1.2× Huntsman CORP). Huntsman CORP runs the higher net margin — -7.1% vs -58.9%, a 51.8% gap on every dollar of revenue. On growth, Invesco posted the faster year-over-year revenue change (6.2% vs -6.7%). Invesco produced more free cash flow last quarter ($432.2M vs $19.0M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs -4.0%).

Huntsman Corporation is an American multinational manufacturer and marketer of chemical products for consumers and industrial customers. Huntsman manufactures assorted polyurethanes, performance products, and adhesives for customers like BMW, GE, Chevron, Procter & Gamble, Unilever and Walkaroo. With global headquarters in The Woodlands, Texas, it operates more than 60 manufacturing, R&D and operations facilities in over 25 countries and employ approximately 7,000 associates across three busi...

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

HUN vs IVZ — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.2× larger
IVZ
$1.7B
$1.4B
HUN
Growing faster (revenue YoY)
IVZ
IVZ
+12.9% gap
IVZ
6.2%
-6.7%
HUN
Higher net margin
HUN
HUN
51.8% more per $
HUN
-7.1%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$413.2M more FCF
IVZ
$432.2M
$19.0M
HUN
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
-4.0%
HUN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HUN
HUN
IVZ
IVZ
Revenue
$1.4B
$1.7B
Net Profit
$-96.0M
$-995.9M
Gross Margin
12.1%
Operating Margin
-4.4%
-86.2%
Net Margin
-7.1%
-58.9%
Revenue YoY
-6.7%
6.2%
Net Profit YoY
31.9%
-575.8%
EPS (diluted)
$-0.56
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HUN
HUN
IVZ
IVZ
Q4 25
$1.4B
$1.7B
Q3 25
$1.5B
$1.6B
Q2 25
$1.5B
$1.5B
Q1 25
$1.4B
$1.5B
Q4 24
$1.5B
$1.6B
Q3 24
$1.5B
$1.5B
Q2 24
$1.6B
$1.5B
Q1 24
$1.5B
$1.5B
Net Profit
HUN
HUN
IVZ
IVZ
Q4 25
$-96.0M
$-995.9M
Q3 25
$-25.0M
$356.4M
Q2 25
$-158.0M
$197.4M
Q1 25
$-5.0M
$171.1M
Q4 24
$-141.0M
$209.3M
Q3 24
$-33.0M
$55.0M
Q2 24
$22.0M
$132.2M
Q1 24
$-37.0M
$141.5M
Gross Margin
HUN
HUN
IVZ
IVZ
Q4 25
12.1%
Q3 25
14.0%
Q2 25
12.5%
Q1 25
14.3%
Q4 24
12.9%
Q3 24
15.2%
Q2 24
15.4%
Q1 24
13.7%
Operating Margin
HUN
HUN
IVZ
IVZ
Q4 25
-4.4%
-86.2%
Q3 25
0.4%
16.5%
Q2 25
-8.2%
14.1%
Q1 25
3.0%
18.1%
Q4 24
-4.3%
19.6%
Q3 24
2.7%
6.6%
Q2 24
2.2%
13.9%
Q1 24
-2.6%
14.4%
Net Margin
HUN
HUN
IVZ
IVZ
Q4 25
-7.1%
-58.9%
Q3 25
-1.7%
21.7%
Q2 25
-10.8%
13.0%
Q1 25
-0.4%
11.2%
Q4 24
-9.7%
13.1%
Q3 24
-2.1%
3.6%
Q2 24
1.4%
8.9%
Q1 24
-2.5%
9.6%
EPS (diluted)
HUN
HUN
IVZ
IVZ
Q4 25
$-0.56
$-2.61
Q3 25
$-0.14
$0.66
Q2 25
$-0.92
$-0.03
Q1 25
$-0.03
$0.38
Q4 24
$-0.82
$0.46
Q3 24
$-0.19
$0.12
Q2 24
$0.13
$0.29
Q1 24
$-0.22
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HUN
HUN
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$429.0M
$1.0B
Total DebtLower is stronger
$2.0B
$1.8B
Stockholders' EquityBook value
$2.8B
$12.2B
Total Assets
$7.0B
$27.1B
Debt / EquityLower = less leverage
0.73×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HUN
HUN
IVZ
IVZ
Q4 25
$429.0M
$1.0B
Q3 25
$468.0M
$973.1M
Q2 25
$399.0M
$922.7M
Q1 25
$334.0M
$821.7M
Q4 24
$340.0M
$986.5M
Q3 24
$330.0M
$1.0B
Q2 24
$335.0M
$878.5M
Q1 24
$552.0M
$895.7M
Total Debt
HUN
HUN
IVZ
IVZ
Q4 25
$2.0B
$1.8B
Q3 25
$2.0B
$1.6B
Q2 25
$2.0B
$1.9B
Q1 25
$2.0B
$964.8M
Q4 24
$1.8B
$890.6M
Q3 24
$1.9B
$890.3M
Q2 24
$1.9B
$890.1M
Q1 24
$2.1B
$1.3B
Stockholders' Equity
HUN
HUN
IVZ
IVZ
Q4 25
$2.8B
$12.2B
Q3 25
$2.8B
$14.0B
Q2 25
$2.8B
$13.9B
Q1 25
$3.0B
$14.7B
Q4 24
$3.0B
$14.6B
Q3 24
$3.1B
$14.8B
Q2 24
$3.1B
$14.6B
Q1 24
$3.2B
$14.6B
Total Assets
HUN
HUN
IVZ
IVZ
Q4 25
$7.0B
$27.1B
Q3 25
$7.1B
$28.4B
Q2 25
$7.1B
$28.5B
Q1 25
$7.2B
$28.1B
Q4 24
$7.1B
$27.0B
Q3 24
$7.3B
$27.5B
Q2 24
$7.3B
$27.2B
Q1 24
$7.6B
$28.1B
Debt / Equity
HUN
HUN
IVZ
IVZ
Q4 25
0.73×
0.15×
Q3 25
0.73×
0.12×
Q2 25
0.72×
0.14×
Q1 25
0.66×
0.07×
Q4 24
0.62×
0.06×
Q3 24
0.60×
0.06×
Q2 24
0.62×
0.06×
Q1 24
0.65×
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HUN
HUN
IVZ
IVZ
Operating Cash FlowLast quarter
$76.0M
$455.8M
Free Cash FlowOCF − Capex
$19.0M
$432.2M
FCF MarginFCF / Revenue
1.4%
25.5%
Capex IntensityCapex / Revenue
4.2%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$116.0M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HUN
HUN
IVZ
IVZ
Q4 25
$76.0M
$455.8M
Q3 25
$196.0M
$606.2M
Q2 25
$91.0M
$547.9M
Q1 25
$-74.0M
$-84.6M
Q4 24
$153.0M
$316.9M
Q3 24
$129.0M
$438.4M
Q2 24
$46.0M
$489.1M
Q1 24
$-65.0M
$-54.4M
Free Cash Flow
HUN
HUN
IVZ
IVZ
Q4 25
$19.0M
$432.2M
Q3 25
$153.0M
$586.4M
Q2 25
$54.0M
$530.4M
Q1 25
$-110.0M
$-108.0M
Q4 24
$102.0M
$309.9M
Q3 24
$88.0M
$410.0M
Q2 24
$-4.0M
$462.4M
Q1 24
$-107.0M
$-75.4M
FCF Margin
HUN
HUN
IVZ
IVZ
Q4 25
1.4%
25.5%
Q3 25
10.5%
35.7%
Q2 25
3.7%
35.0%
Q1 25
-7.8%
-7.1%
Q4 24
7.0%
19.5%
Q3 24
5.7%
27.1%
Q2 24
-0.3%
31.2%
Q1 24
-7.3%
-5.1%
Capex Intensity
HUN
HUN
IVZ
IVZ
Q4 25
4.2%
1.4%
Q3 25
2.9%
1.2%
Q2 25
2.5%
1.2%
Q1 25
2.6%
1.5%
Q4 24
3.5%
0.4%
Q3 24
2.7%
1.9%
Q2 24
3.2%
1.8%
Q1 24
2.9%
1.4%
Cash Conversion
HUN
HUN
IVZ
IVZ
Q4 25
Q3 25
1.70×
Q2 25
2.78×
Q1 25
-0.49×
Q4 24
1.51×
Q3 24
7.97×
Q2 24
2.09×
3.70×
Q1 24
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HUN
HUN

Diversified$897.0M66%
Specialty$231.0M17%
Performance Products$113.0M8%
Advanced Materials$61.0M5%
Related Party Customers$19.0M1%
Other$12.0M1%

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons